Taiwan FDA: No drug shortages amid Israel-Palestine conflict

記者 Huang-Chi Ho 報導

2023/10/11 19:29

TAIPEI (TVBS News) — The Taiwan Food and Drug Administration (FDA) reassured the public on Tuesday (Oct. 10) that the nation has a sufficient medication supply in the wake of the Israeli-Palestinian conflict.

The ongoing Israeli-Palestinian conflict has impacted the pharmaceutical industry worldwide and raised concerns regarding potential medication shortages in Taiwan. 

 


In response, FDA Deputy Director-General, Chen Hui-fang, stated that current assessments suggest the conflict will not impact Taiwan's national medicine supply for the time being. 

Pharmacist Huang Yen-ju pointed out that Azilect, an Israeli-produced medication primarily used to treat Parkinson's disease, may experience disruptions due to the ongoing conflict. Fortunately, a domestically-produced alternative named Rakinson is readily available.

Recognizing the uncertainty about the conflict's duration, the Ministry of Foreign Affairs (MOFA) disclosed that discussions regarding a citizen evacuation plan are in progress. They pledged to provide further updates in forthcoming press releases.
 

 

【永續生活選品】

👉一開賣就完售?民眾超商瘋掃貨!

👉ESG怎麼做? 永續香氛禮贈幫你達成

👉上班族的提神秘訣、助消化小物推薦


更新時間:2023/10/11 19:29

延伸閱讀